• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血红蛋白病患者造血干细胞移植后残余供体红系祖细胞的检测

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies.

作者信息

Crazzolara Roman, Kropshofer Gabriele, Steurer Michael, Sopper Sieghart, Schwinger Wolfgang

机构信息

Department of Pediatrics, Medical University Innsbruck;

Department of Pediatrics, Medical University Innsbruck.

出版信息

J Vis Exp. 2017 Sep 6(127):56002. doi: 10.3791/56002.

DOI:10.3791/56002
PMID:28930976
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5752172/
Abstract

The presence of incomplete chimerism is noted in a large proportion of patients following bone marrow transplant for thalassemia major or sickle cell disease. This observation has tremendous implications, as subsequent therapeutic immunomodulation strategies can improve clinical outcome. Conventionally, polymerase chain reaction-based analysis of short tandem repeats is used to identify chimerism in donor-derived blood cells. However, this method is restricted to nucleated cells and cannot distinguish between dissociated single-cell lineages. We applied the analysis of short tandem repeats to flow cytometric-sorted hematopoietic progenitor cells and compared this with the analysis of short tandem repeats obtained from selected burst-forming unit - erythroid colonies, both collected from the bone marrow. With this method we are able to demonstrate the different proliferation and differentiation of donor cells in the erythroid compartment. This technique is eligible to complete current monitoring of chimerism in the stem cell transplant setting and thus may be applied in future clinical studies, stem cell research and design of gene therapy trials.

摘要

在接受骨髓移植治疗重型地中海贫血或镰状细胞病的大部分患者中,发现存在不完全嵌合现象。这一观察结果具有重大意义,因为后续的治疗性免疫调节策略可改善临床结局。传统上,基于聚合酶链反应的短串联重复序列分析用于识别供体来源血细胞中的嵌合现象。然而,该方法仅限于有核细胞,无法区分解离的单细胞谱系。我们将短串联重复序列分析应用于流式细胞术分选的造血祖细胞,并将其与从骨髓中收集的选定红系爆式集落形成单位获得的短串联重复序列分析进行比较。通过这种方法,我们能够证明供体细胞在红系区室中的不同增殖和分化情况。这项技术有资格完成当前干细胞移植环境中的嵌合监测,因此可能应用于未来的临床研究、干细胞研究以及基因治疗试验的设计。

相似文献

1
Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies.血红蛋白病患者造血干细胞移植后残余供体红系祖细胞的检测
J Vis Exp. 2017 Sep 6(127):56002. doi: 10.3791/56002.
2
Quantitatively different red cell/nucleated cell chimerism in patients with long-term, persistent hematopoietic mixed chimerism after bone marrow transplantation for thalassemia major or sickle cell disease.在因重型地中海贫血或镰状细胞病而接受骨髓移植后长期、持续存在造血混合嵌合体的患者中,存在定量不同的红细胞/有核细胞嵌合体。
Haematologica. 2011 Jan;96(1):128-33. doi: 10.3324/haematol.2010.031013. Epub 2010 Oct 7.
3
Mixed chimerism following in utero hematopoietic stem cell transplantation in murine models of hemoglobinopathy.血红蛋白病小鼠模型中宫内造血干细胞移植后的混合嵌合体。
Exp Hematol. 2003 Feb;31(2):176-84. doi: 10.1016/s0301-472x(02)01024-x.
4
Allogeneic Stem Cell Transplantation in Congenital Hemoglobinopathies Using a Tailored Busulfan-Based Conditioning Regimen: Single-Center Experience.使用定制的基于白消安的预处理方案进行先天性血红蛋白病的异基因干细胞移植:单中心经验
Biol Blood Marrow Transplant. 2016 Jun;22(6):1043-1048. doi: 10.1016/j.bbmt.2016.03.003. Epub 2016 Mar 23.
5
Transient and permanent engraftment potential of murine hematopoietic stem cell subsets: differential effects of host conditioning with gamma radiation and cytotoxic drugs.小鼠造血干细胞亚群的短暂和永久植入潜力:γ射线照射和细胞毒性药物对宿主预处理的不同影响。
Exp Hematol. 1993 Jul;21(7):913-21.
6
Late Effects Screening Guidelines after Hematopoietic Cell Transplantation (HCT) for Hemoglobinopathy: Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric HCT.血红蛋白病造血细胞移植(HCT)后晚期效应筛查指南:第二届儿科血液和骨髓移植国际会议关于儿科 HCT 后晚期效应的共识声明。
Biol Blood Marrow Transplant. 2018 Jul;24(7):1313-1321. doi: 10.1016/j.bbmt.2018.04.002. Epub 2018 Apr 10.
7
Allogeneic cellular gene therapy for hemoglobinopathies.同种异体细胞基因治疗血红蛋白病。
Hematol Oncol Clin North Am. 2010 Dec;24(6):1145-63. doi: 10.1016/j.hoc.2010.08.004. Epub 2010 Sep 29.
8
Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.异基因反应性作为血液系统恶性肿瘤治疗的治疗原则。非清髓性预处理的异基因造血细胞移植的临床和免疫学方面的研究。
Dan Med Bull. 2007 May;54(2):112-39.
9
The second mini-transplant for unstable mixed chimerism within the first 100 days after hematopoietic stem cell transplant in severe thalassemia.重型地中海贫血造血干细胞移植后100天内针对不稳定混合嵌合体的第二次小型移植。
Pediatr Transplant. 2012 Sep;16(6):E238-40. doi: 10.1111/j.1399-3046.2011.01577.x. Epub 2011 Sep 5.
10
Impact of T cell chimerism on clinical outcome in 117 patients who underwent allogeneic stem cell transplantation with a busulfan-containing reduced-intensity conditioning regimen.117例接受含白消安的减低强度预处理方案的异基因干细胞移植患者中T细胞嵌合状态对临床结局的影响。
Biol Blood Marrow Transplant. 2008 Oct;14(10):1148-1155. doi: 10.1016/j.bbmt.2008.07.013.

引用本文的文献

1
Eradication of Therapy-Resistant Cancer Stem Cells by Novel Telmisartan Derivatives.新型替米沙坦衍生物对治疗抵抗性癌症干细胞的根除作用
J Med Chem. 2025 Jan 9;68(1):287-306. doi: 10.1021/acs.jmedchem.4c01865. Epub 2024 Dec 18.

本文引用的文献

1
Successful management of mixed chimerism after bone marrow transplant in beta-thalassemia major.重型β地中海贫血骨髓移植后混合嵌合体的成功管理。
Am J Hematol. 2016 Sep;91(9):E357-8. doi: 10.1002/ajh.24436. Epub 2016 Jul 4.
2
Hematopoietic stem cell transplantation in thalassemia major and sickle cell disease: indications and management recommendations from an international expert panel.重型地中海贫血和镰状细胞病的造血干细胞移植:国际专家小组的适应证及管理建议
Haematologica. 2014 May;99(5):811-20. doi: 10.3324/haematol.2013.099747.
3
Mixed chimerism in haemoglobinopathies: from risk of graft rejection to immune tolerance.血红蛋白病中的混合嵌合体:从移植物排斥风险到免疫耐受
Tissue Antigens. 2014 Mar;83(3):137-46. doi: 10.1111/tan.12313.
4
Pilot study of prophylactic ex vivo costimulated donor leukocyte infusion after reduced-intensity conditioned allogeneic stem cell transplantation.减强度预处理异基因造血干细胞移植后预防性体外激活供者白细胞输注的初步研究。
Biol Blood Marrow Transplant. 2013 Jul;19(7):1094-101. doi: 10.1016/j.bbmt.2013.04.021. Epub 2013 Apr 28.
5
Hematopoietic stem cell transplantation in thalassemia and sickle cell anemia.地中海贫血和镰状细胞贫血的造血干细胞移植。
Cold Spring Harb Perspect Med. 2012 May;2(5):a011825. doi: 10.1101/cshperspect.a011825.
6
Split chimerism between nucleated and red blood cells after bone marrow transplantation for haemoglobinopathies.血红蛋白病患者骨髓移植后有核细胞与红细胞之间的嵌合现象。
Chimerism. 2011 Jan;2(1):21-2. doi: 10.4161/chim.2.1.15057.
7
Quantitatively different red cell/nucleated cell chimerism in patients with long-term, persistent hematopoietic mixed chimerism after bone marrow transplantation for thalassemia major or sickle cell disease.在因重型地中海贫血或镰状细胞病而接受骨髓移植后长期、持续存在造血混合嵌合体的患者中,存在定量不同的红细胞/有核细胞嵌合体。
Haematologica. 2011 Jan;96(1):128-33. doi: 10.3324/haematol.2010.031013. Epub 2010 Oct 7.
8
In vivo selection of genetically modified erythroblastic progenitors leads to long-term correction of beta-thalassemia.体内对基因编辑的成红细胞祖细胞进行选择可实现β地中海贫血的长期纠正。
Proc Natl Acad Sci U S A. 2008 Jul 29;105(30):10547-52. doi: 10.1073/pnas.0711666105. Epub 2008 Jul 23.
9
Hemopoietic chimerism following stem cell transplantation.干细胞移植后的造血嵌合现象。
Transfus Apher Sci. 2005 Feb;32(1):55-61. doi: 10.1016/j.transci.2004.10.006.
10
The importance of erythroid expansion in determining the extent of apoptosis in erythroid precursors in patients with beta-thalassemia major.在重型β地中海贫血患者中,红系扩增在确定红系前体细胞凋亡程度方面的重要性。
Blood. 2000 Nov 15;96(10):3624-9.